Characterization of Genome Integrity for Oversized Recombinant AAV Vector

Dong, Biao, Nakai, Hiroyuki, Xiao, Weidong·2010·Molecular Therapy
DOI 10.1038/mt.2009.258

Cited by (231)

Items 101–200 of 231

  1. Molecular analysis of AAV5-hFVIII-SQ vector-genome-processing kinetics in transduced mouse and nonhuman primate livers
    Choong‐Ryoul Sihn, Britta Handyside, Su Liu, Lening Zhang, Ryan Murphy, Bridget Yates, Lin Ying Xie, Richard Torres, Chris B. Russell, Charles A. O’neill et al. · 2021 · Molecular Therapy — Methods & Clinical Development
  2. Optogenetic Neuromodulation
    Paul S. A. Kalanithi, Jaimie M. Henderson · 2012 · International review of neurobiology
  3. Voretigene Neparvovec and Gene Therapy for Leber’s Congenital Amaurosis: Review of Evidence to Date
    Srikanta Kumar Padhy, Brijesh Takkar, Raja Narayanan, Pradeep Venkatesh, Subhadra Jalali · 2020 · The Application of Clinical Genetics
  4. Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice
    Agnese Padula, Raffaella Petruzzelli, Sasha A. Philbert, Stephanie J. Church, Federica Esposito, Severo Campione, Marcello Monti, Filomena Capolongo, Claudia Perna, Edoardo Nusco et al. · 2022 · Molecular Therapy — Methods & Clinical Development
  5. Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A
    Vanda S. Lopes, David S. Williams · 2015 · Cold Spring Harbor Perspectives in Medicine
  6. Gene replacement therapy for retinal CNG channelopathies
    Christian Schön, Martin Biel, Stylianos Michalakis · 2013 · Molecular Genetics and Genomics
  7. Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action
    Akihiko Ozawa, Hiroyuki Arakawa · 2021 · Behavioural Brain Research
  8. Natural History of Cone Disease in the Murine Model of Leber Congenital Amaurosis Due to CEP290 Mutation: Determining the Timing and Expectation of Therapy
    Shannon E. Boye, Wei-Chieh Huang, Alejandro J. Román, Alexander Sumaroka, Sanford L. Boye, Renee C. Ryals, Melani B. Olivares, Qing Ruan, Budd A. Tucker, Edwin M. Stone et al. · 2014 · PLoS ONE
  9. The use of viral vectors to promote repair after spinal cord injury
    Ashraful Islam, Veronica J. Tom · 2022 · Experimental Neurology
  10. Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges
    Roni Hahn, Karen B. Avraham · 2023 · Audiology Research
  11. Recombinant AAV-directed gene therapy for type I glycogen storage diseases
    JANICE YANG CHOU, Brian C. Mansfield · 2011 · Expert Opinion on Biological Therapy
  12. Adeno-Associated Viral Vectors for Gene Therapy of Inherited Retinal Degenerations
    John G. Flannery, Meike Visel · 2012 · Methods in molecular biology
  13. A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes
    Laura P. van Lieshout, Miranda Rubin, Katrina Costa-Grant, Stacy Ota, Diane Golebiowski, Troy Panico, Eli Wiberg, Klaudia Szymczak, Richard Gilmore, Marissa Stanvick et al. · 2023 · Molecular Therapy — Methods & Clinical Development
  14. Long-term labeling and imaging of synaptically connected neuronal networks in vivo using double-deletion-mutant rabies viruses
    Lei Jin, Heather A. Sullivan, Mulangma Zhu, Thomas K. Lavin, Makoto Matsuyama, Xin Fu, Nicholas E. Lea, Ran Xu, Yuanyuan Hou, Luca Rutigliani et al. · 2024 · Nature Neuroscience
  15. Cav1.4 dysfunction and congenital stationary night blindness type 2
    Alexandra Koschak, Monica L. Fernández‐Quintero, Thomas Heigl, M. R. Di Ruzza, Hartwig Seitter, Lucia Zanetti · 2021 · Pflügers Archiv - European Journal of Physiology
  16. Deciphering Memory Function with Optogenetics
    Anna Beyeler, Christine A. Eckhardt, Kay M. Tye · 2014 · Progress in molecular biology and translational science
  17. Application of viral vectors to the study of neural connectivities and neural circuits in the marmoset brain
    Akiya Watakabe, Osamu Sadakane, Katsusuke Hata, Masanari Ohtsuka, Masafumi Takaji, Tetsuo Yamamori · 2016 · Developmental Neurobiology
  18. Exploiting Natural Diversity of AAV for the Design of Vectors with Novel Properties
    Guangping Gao, Zhong Li, Olivier Danos · 2011 · Methods in molecular biology
  19. In Vivo Gene Transfer Strategies to Achieve Partial Correction of von Willebrand Disease
    Lan Wang, Jonathan B. Rosenberg, Bishnu P. De, Barbara Ferris, Rui Wang, Stefano Rivella, Stephen M. Kaminsky, Ronald G. Crystal · 2012 · Human Gene Therapy
  20. Perinatal systemic gene delivery using adeno-associated viral vectors
    Rajvinder Karda, Suzanne M. K. Buckley, Citra Nurfarah Zaini Mattar, Joanne Ng, Giulia Massaro, Michael P. Hughes, Manju A. Kurian, Julien Baruteau, Paul Gissen, Jerry Kok Yen Chan et al. · 2014 · Frontiers in Molecular Neuroscience
  21. Cystic fibrosis transmembrane conductance regulator with a shortened R domain rescues the intestinal phenotype of CFTR −/− mice
    Lynda S. Ostedgaard, David Kyle Meyerholz, Daniel W. Vermeer, Philip H. Karp, Lindsey Schneider, Curt D. Sigmund, Michael J. Welsh · 2011 · Proceedings of the National Academy of Sciences
  22. Retina-directed gene therapy: Achievements and remaining challenges
    Josef Biber, Catharina L.A. Gandor, Elvir Bećirović, Stylianos Michalakis · 2025 · Pharmacology & Therapeutics
  23. rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application
    Fabian Blanc, Michel Mondain, Alexis‐Pierre Bemelmans, Corentin Affortit, Jean‐Luc Puel, Jing Wang · 2020 · Journal of Clinical Medicine
  24. Strategies for Targeting Neural Circuits: How to Manipulate Neurons Using Virus Vehicles
    Yuqing Hui, Xue-Feng Zheng, Huijie Zhang, Fang Li, Guang-Yin Yu, Jiong Li, Ji-Feng Zhang, Xiao-Bing Gong, Guo-Qing Guo · 2022 · Frontiers in Neural Circuits
  25. Fast-Seq, a simple method for rapid and inexpensive validation of packaged ssAAV genomes in academic settings
    Lucy H. Maynard, Olivia Smith, Nicolas P. Tilmans, Eléonore Tham, Shayan Hosseinzadeh, Weilun Tan, Ryan T. Leenay, Andrew P. May, Nicole K. Paulk · 2019 · Human Gene Therapy Methods
  26. Advances in engineering CRISPR-Cas9 as a molecular Swiss Army knife
    Grace A. Meaker, Emma J. Hair, Thomas E. Gorochowski · 2020 · Synthetic Biology
  27. Nonviral targeted mRNA delivery: principles, progresses, and challenges
    Xi He, Guohong Li, Letao Huang, Haixing Shi, Sha Zhong, Siyu Zhao, Xiangyu Jiao, Jinxiu Xin, Xiaoling Yin, Shengbin Liu et al. · 2025 · MedComm
  28. Delivery of large transgene cassettes by foamy virus vector
    Nathan P. Sweeney, Jinhong Meng, Hayley Patterson, Jennifer Elizabeth Morgan, Myra O. McClure · 2017 · Scientific Reports
  29. Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice
    Buel D. Rodgers, Yemeserach M. Bishaw, Denali R. Kagel, Julian N. Ramos, Joseph W. Maricelli · 2019 · Molecular Therapy — Methods & Clinical Development
  30. Split AAV-Mediated Gene Therapy Restores Ureagenesis in a Murine Model of Carbamoyl Phosphate Synthetase 1 Deficiency
    Matthew Nitzahn, Gabriella Allegri, Suhail Khoja, Brian Truong, Georgios Makris, Johannes Häberle, Gerald S. Lipshutz · 2020 · Molecular Therapy
  31. AAV-mediated gene therapies by miniature gene editing tools
    Xiangfeng Kong, Tong Li, Hui Yang · 2024 · Science China Life Sciences
  32. Gene therapy approaches for prevention of retinal degeneration in Usher syndrome
    David S. Williams, Abhishek Chadha, Roni A. Hazim, Daniel Gibbs · 2017 · Gene Therapy
  33. Engineering of the AAV-Compatible Hair Cell-Specific Small-Size Myo15 Promoter for Gene Therapy in the Inner Ear
    Shao Wei Hu, Jun Lv, Zijing Wang, Honghai Tang, Hui Wang, Fang Wang, Daqi Wang, Juan Zhang, Longlong Zhang, Qi Cao et al. · 2024 · Research
  34. The ABCs of Stargardt disease: the latest advances in precision medicine
    Yasmine A. Zaydon, Stephen H. Tsang · 2024 · Cell & Bioscience
  35. The impact of minimally oversized adeno-associated viral vectors encoding human factor VIII on vector potency in vivo
    Sirkka Kyostio-Moore, Patricia Berthelette, Susan Piraino, Cathleen Sookdeo, Bindu Nambiar, Robert Jackson, Brenda L. Burnham, Catherine R. O’Riordan, Seng H. Cheng, Donna Armentano · 2016 · Molecular Therapy — Methods & Clinical Development
  36. Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection
    Bindu Nambiar, Cathleen Sookdeo, Patricia Berthelette, Robert Jackson, Susan Piraino, Brenda L. Burnham, Shelley Nass, David W. Souza, Catherine R. O’Riordan, Karen A. Vincent et al. · 2017 · Human Gene Therapy Methods
  37. Effects of Thermally Induced Configuration Changes on rAAV Genome’s Enzymatic Accessibility
    Yinxia Xu, Ping Guo, Junping Zhang, Matthew Chrzanowski, Helen Chew, Jenni Firrman, Nianli Sang, Yong Diao, Weidong Xiao · 2020 · Molecular Therapy — Methods & Clinical Development
  38. A novel class of self-complementary AAV vectors with multiple advantages based on cceAAV lacking mutant ITR
    Junping Zhang, Dylan A. Frabutt, Matthew Chrzanowski, Ning Li, Lohra M. Miller, Jiahe Tian, Patrick L. Mulcrone, Anh K. Lam, Benjamin E. Draper, Martin F. Jarrold et al. · 2024 · Molecular Therapy — Methods & Clinical Development
  39. Retinal gene therapy: current progress and future prospects
    Cristy A. Ku, Mark Edward Pennesi · 2015 · Expert Review of Ophthalmology
  40. Current and future prospects for hemophilia gene therapy
    Peter Ward, Christopher Walsh · 2016 · Expert Review of Hematology
  41. High-Throughput Screening Identifies Kinase Inhibitors That Increase Dual Adeno-Associated Viral Vector Transduction In Vitro and in Mouse Retina
    Andrea Maddalena, Fabio Dell’Aquila, Pia Giovannelli, Paola Tiberi, Luca G. Wanderlingh, Sandro Montefusco, Patrizia Tornabene, Carolina Iodice, Feliciano Visconte, Annamaria Carissimo et al. · 2018 · Human Gene Therapy
  42. Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
    Wang Qizhao, Biao Dong, Katie A. Pokiniewski, Jenni Firrman, Zhongren Wu, Mario P. S. Chin, Xiongwen Chen, LinShu Liu, Ruian Xu, Yong Diao et al. · 2016 · Molecular Therapy — Methods & Clinical Development
  43. Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing
    Mitsuki Kosaka, Ai Fujita Sajiki, Kosuke Fujita, Kazuhisa Yamada, Kenichi Kawano, Kiichi Hirazawa, Tsuyoshi Matsuno, Masahiko Takada, Nobuhiro Shimozawa, Kenichi Inoue et al. · 2025 · Molecular Therapy — Methods & Clinical Development
  44. Thorough molecular configuration analysis of noncanonical AAV genomes in AAV vector preparations
    Junping Zhang, Xiangping Yu, Matthew Chrzanowski, Jiahe Tian, Derek J. Pouchnik, Ping Guo, Roland W. Herzog, Weidong Xiao · 2024 · Molecular Therapy — Methods & Clinical Development
  45. Adeno Associated Virus (AAV) as a Tool for Clinical and Experimental Delivery of Target Genes into the Mammalian Retina
    Tesshu Hori, Masashi Fukutome, Chieko Koike · 2019 · Biological and Pharmaceutical Bulletin
  46. Enhancement of rAAV2-Mediated Transgene Expression in Retina Cells In Vitro and In Vivo by Coadministration of Low-Dose Chemotherapeutic Drugs
    Shenghai Zhang, Jihong Wu, Xiaobing Wu, Ping Xu, Yuhua Tian, Yi Miaoying, Xinjian Liu, Xiaoyan Dong, Frank Wolf, Chuan‐Yuan Li et al. · 2012 · Investigative Ophthalmology & Visual Science
  47. Engineering Factor Viii for Hemophilia Gene Therapy
    Sean A. Roberts, Biao Dong, Jenni Firrman · 2012 · Journal of Genetic Syndromes & Gene Therapy
  48. AAV-mediated base editing restores cochlear gap junction in GJB2 dominant-negative mutation-associated syndromic hearing loss model
    Takao Ukaji, Daisuke Arai, Harumi Tsutsumi, Ryoya Nakagawa, Fumihiko Matsumoto, Katsuhisa Ikeda, Osamu Nureki, Kazusaku Kamiya · 2025 · JCI Insight
  49. Gene therapy – are we ready now?
    Radosław Kaczmarek · 2022 · Haemophilia
  50. A Fragmented Adeno-Associated Viral Dual Vector Strategy for Treatment of Diseases Caused by Mutations in Large Genes Leads to Expression of Hybrid Transcripts
    McClements, Michelle E, Charbel Issa, Peter, Blouin, Veronique, MacLaren, Robert E · 2016 · Journal of Genetic Syndromes & Gene Therapy
  51. Liver gene therapy with intein‐mediated F8 trans‐splicing corrects mouse haemophilia A
    Federica Esposito, Hristiana Lyubenova, Patrizia Tornabene, Stefano Auricchio, Antonella Iuliano, Edoardo Nusco, Simone Merlin, Cristina Olgasi, Giorgia Manni, Marco Gargaro et al. · 2022 · EMBO Molecular Medicine
  52. In vivo delivery systems for CRISPR genome editing: Viral and non-viral carriers
    Yeeun Lee, Bookun Kim, Donghyun Lee, Seo Young Cheon, Seong Gi Lim, Younggwang Kim, Heebeom Koo · 2025 · Applied Physics Reviews
  53. Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential
    Fan Wu, Wuhui He, Yun Xiao, Qiong Wu, Qing Zhang, Tiesong Zhang, Lei Xu, Xinyi Pang · 2025 · Advanced Science
  54. Vector Systems for Prenatal Gene Therapy: Principles of Adeno-Associated Virus Vector Design and Production
    Christopher Binny, Amit Chunilal Nathwani · 2012 · Humana Press eBooks
  55. Genome length determination in adeno-associated virus vectors with mass photometry
    Cornelia Hiemenz, Nadine Baumeister, Constanze Helbig, Andrea Hawe, Sabrina Babutzka, Stylianos Michalakis, Wolfgang Frieß, Tim Menzen · 2023 · Molecular Therapy — Methods & Clinical Development
  56. Clinical applications of retinal gene therapies
    Xin Fu, Viet Anh Nguyen Huu, Yaou Duan, Daniel Kermany, Carolina C. S. Valentim, Runze Zhang, Jie Zhu, Charlotte L Zhang, Xiaodong Sun, Kang Zhang · 2018 · Precision Clinical Medicine
  57. Enhanced sensitivity of neutralizing antibody detection for different AAV serotypes using HeLa cells with overexpressed AAVR
    Zhaoyue Zheng, Jingya Ye, Mi Leng, Chunmei Gan, Na Tang, Wei Li, C. Alexander Valencia, Biao Dong, Hoi Yee Chow · 2023 · Frontiers in Pharmacology
  58. Delivering Large Therapeutic Genes for Muscle Gene Therapy
    Yi Lai, Yongping Yue, Brian Bostick, Dongsheng Duan · 2009 · Springer eBooks
  59. Optimization of AAV vectors for transactivator-regulated enhanced gene expression within targeted neuronal populations
    Leo Kojima, Kaoru Seiriki, Hiroki Rokujo, Takanobu Nakazawa, Atsushi Kasai, Hitoshi Hashimoto · 2024 · iScience
  60. Pre-Existing Anti-Adeno-Associated Virus Immunity in Gene Therapy: Mechanisms, Challenges, and Potential Solutions
    Godwin I. Iroanya, Pradeep N. Subramanyam, Kevin Dale Wells, Jonathan A. Green · 2025 · Human Gene Therapy
  61. Adeno-Associated Viral Gene Therapy for Retinal Disorders
    Samantha Roshani De Silva, Michelle E. McClements, Mark W. Hankins, Robert Edward MacLaren · 2015 · Neuromethods
  62. Evaluation of the biological differences of canine and human factor VIII in gene delivery: implications in human hemophilia treatment
    Wang Qizhao, Biao Dong, Jenni Firrman, Wanling Wu, S Roberts, A R Moore, LinShu Liu, Mario P. S. Chin, Yong Diao, Joseph Kost et al. · 2016 · Gene Therapy
  63. Preparation and Administration of Adeno-associated Virus Vectors for Corneal Gene Delivery
    Liujiang Song, Jacquelyn J. Bower, Matthew Louis Hirsch · 2020 · Methods in molecular biology
  64. Planet of the AAVs: The Spinal Cord Injury Episode
    Kateřina Štěpánková, Pavla Jendelová, Lucia Machová Urdzíková · 2021 · Biomedicines
  65. Basic Concepts in Viral Vector-Mediated Gene Therapy
    Matthew J. Benskey, Ivette M. Sandoval, Kathryn Miller, Rhyomi C. Sellnow, Aysegul O. Gezer, Nathan C. Kuhn, Roslyn Vashon, Fredric P. Manfredsson · 2019 · Methods in molecular biology
  66. Electrophoresis-Mediated Characterization of Full and Empty Adeno-Associated Virus Capsids
    Adriana Coll De Peña, Lucy Masto, James Atwood, Anubhav Tripathi · 2022 · ACS Omega
  67. Selection of a novel AAV2/TNFAIP3 vector for local suppression of islet xenograft inflammation
    Nathan W. Zammit, Karen L. Seeberger, Jad Zamerli, Stacey N. Walters, Leszek Lisowski, Gregory S. Korbutt, Shane T. Grey · 2020 · Xenotransplantation
  68. Concise Analysis of Single-Stranded DNA of Recombinant Adeno-Associated Virus By Automated Electrophoresis System
    Yuzhe Yuan, Kiyoko Higashiyama, Noriko Hashiba, Kyoko Masumi‐Koizumi, Keisuke Yusa, Kazuhisa Uchida · 2023 · Human Gene Therapy
  69. The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver
    Chunmei Gan, Mi Leng, Yu Liu, Zhaoyue Zheng, Shufang He, Wen Qiao, Xiao Lin, Yao Xiao, Jingya Ye, Lixing Zhou et al. · 2024 · Molecular Therapy — Methods & Clinical Development
  70. Adeno-Associated Virus as Gene Delivery Vehicle into the Retina
    Shuyun Deng, Kazuhiro Oka · 2019 · Methods in molecular biology
  71. Characterization of Viral Genome Encapsidated in Adeno-associated Recombinant Vectors Produced in Yeast Saccharomyces cerevisiae
    Alvaro Galli, Ilenia Iaia, Maria Serena Milella, Filippo Cipriani, Veronica Della Latta, Mauro Giacca, Lorena Zentilin, Tiziana Cervelli · 2021 · Molecular Biotechnology
  72. TIGER: Single-step in vivo genome editing in a non-traditional rodent
    Sha Li, Sarah A. Mereby, Megan Rothstein, Matthew R. Johnson, Benjamin J. Brack, Ricardo Mallarino · 2023 · Cell Reports
  73. Evaluation of the activity levels of rat FVIII and human FVIII delivered by adeno-associated viral vectors both in vitro and in vivo
    Wei Zhang, Jianhua Mao, Yan Shen, Guowei Zhang, Yanyan Shao, Zheng Ruan, Yun Wang, Wenman Wu, Xuefeng Wang, Jiang Zhu et al. · 2018 · Blood Cells Molecules and Diseases
  74. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy
    Umut Cagin · 2021 · Advances in experimental medicine and biology
  75. A dual‐reference study design for understanding and improving AAV genome size analysis
    Yali Sun, Zhixiang Lu, Michael D. Miller, Ying Valcour, Anis H. Khimani, Jana Bauer, Michael Salomon, Yanhong Tong · 2024 · Electrophoresis
  76. AAV Vector-Based Gene Therapy, Progress and Current Challenges
    Klaudia Kuranda, Federico Mingozzi · 2017 · Springer eBooks
  77. Long-term labeling and imaging of synaptically-connected neuronal networks in vivo using double-deletion-mutant rabies viruses
    Lei Jin, Heather A. Sullivan, Mulangma Zhu, Thomas K. Lavin, Makoto Matsuyama, Xin Fu, Nicholas E. Lea, Ran Xu, Yuanyuan Hou, Luca Rutigliani et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Gene Therapy Strategies for Usher Syndrome Type 1B
    David S. Williams, Vanda S. Lopes · 2011 · Advances in experimental medicine and biology
  79. Activation of spleen tyrosine kinase (SYK) contributes to neuronal pyroptosis and cognitive impairment in diabetic mice via the NLRP3/Caspase-1/GSDMD signaling pathway
    Chenglong Zhou, Jun Li, Xiaochu Wu, Fei Liu · 2024 · Experimental Gerontology
  80. Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control
    Taryn Diep, Wesley Zhou, Rachel E. Reyes, Matthew Nitzahn, Isabel L Day, Georgios Makris, Lindsay M. Lueptow, Irina Zhuravka, Stuti Bakshi, Jon A. Gangoiti et al. · 2025 · Molecular Therapy — Nucleic Acids
  81. Modulating the activity of human nociceptors with a SCN10A promoter-specific viral vector tool
    Stephanie Mouchbahani-Constance, Camille Lagard, Justine Schweizer, Isabelle Labonté, Miltiadis Georgiopoulos, Colombe Otis, Manon St. Louis, Éric Troncy, Philippe Sarret, Alfredo Ribeiro‐da‐Silva et al. · 2023 · Neurobiology of Pain
  82. Assessment of Different Virus-Mediated Approaches for Retinal Gene Therapy of Usher 1B
    Vanda S. Lopes, Tanja Diemer, David S. Williams · 2014 · Advances in experimental medicine and biology
  83. Adeno-Associated Vectors for Gene Delivery to the Nervous System
    Pádraig J. Mulcahy, Christopher Binny, Bartosz Muszynski, Evangelia Karyka, Mimoun Azzouz · 2015 · Neuromethods
  84. Prime editing of the β 1 adrenoceptor in the brain reprograms mouse behavior
    Desirée Böck, Lisa Tidecks, Maria Wilhelm, Yanik Weber, Eleonora I. Ioannidi, Jonas Mumenthaler, Tanja Rothgangl, Lukas Schmidheini, Sharan Janjuha, Tommaso Patriarchi et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Genomic Size Is Critical to Guarantee the Genomic Stability of Non-Replicative HSV1 Vectors
    Justine Basset, Alexandra Seraffin, Julien Ratelade, Yohann Dickx, Tomasz H. Benedyk, Grzegorz Sarek, Teddy Jégu, Alberto Luis Epstein · 2025 · International Journal of Molecular Sciences
  86. Gene and Cell Therapy for Inborn Errors of Metabolism
    Cary O. Harding · 2016 · Springer eBooks
  87. A Hitchhiker’s Guide to the Selection of Viral Vectors for Optogenetic Studies
    Kimberly R. Thompson, Chris L. Towne · 2017 · Neuromethods
  88. Challenges to Gene Editing Approaches in the Retina
    Mario Bonillo, Julia K. Pfromm, Manuel Dominik Fischer · 2022 · Klinische Monatsblätter für Augenheilkunde
  89. Dual-AAV mediated transfer of full-length otoferlin cDNA into auditory inner hair cells and the effects of different mutations in the OTOF gene on the protein levels and cellular distribution of otoferlin in auditory inner hair cells
    Hanan Al‐Moyed · 2019
  90. Treatment of a metabolic liver disease by in vivo prime editing in mice
    Desirée Böck, Tanja Rothgangl, Lukas Villiger, Lukas Schmidheini, Nicholas Mathis, Eleonora I. Ioannidi, Susanne Kreutzer, Zacharias Kontarakis, Nicole Rimann, Hiu Man Grisch‐Chan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Gene modification: Exploring the potential in treating kidney diseases
    Ubong S. Ekperikpe, Serena Zhao, Ilse Sofia Daehn · 2026 · Pharmacological Research
  92. Recombinant Viral Vectors for Investigating DNA Damage Responses and Gene Therapy of Xeroderma Pigmentosum
    Carolina Quayle, Carlos Frederico Martins Menck, Keronninn Moreno · 2011 · InTech eBooks
  93. Development of Next-Generation Muscle Gene Therapy AAV Vectors
    Michael E. Nance, Dongsheng Duan · 2019 · Springer eBooks
  94. Virus Vectors for Optogenetic Prosthetization of the Retina
    A. Yu. Rotov, Darya A. Nikolaeva, Luba A. Astakhova, M. L. Firsov · 2020 · Neuroscience and Behavioral Physiology
  95. Development of viral & non-viral episomal vectors for gene therapy applications
    Hanna Kymäläinen · 2012 · OpenGrey (Institut de l'Information Scientifique et Technique)
  96. Recombinant Adeno-Associated Virus Production, the Beginning of the End of Uncertainty
    Weidong Xiao, Richard Jude Samulski · 2022 · Human Gene Therapy
  97. Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems
    Dalton W. Staller, Flobater I. Gawargi, Sanjali S. Panigrahi, Paras Kumar Mishra, Ram I. Mahato · 2025 · Pharmacological Reviews
  98. Prime editing of the β1 adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease
    Desirée Böck, Lisa Tidecks, Maria Wilhelm, Waleed ElGrawani, Sian N. Duss, Chiara Trevisan, Dalila Laura Vena, Anna Maria Reuss, Lucas Kissling, Matteo Ranucci et al. · 2025 · Nature Communications
  99. AAV-mediated gene transfer of a novel microdystrophin ameliorates pathology and enhances muscle function in a mouse model of DMD
    Lawrence Owusu, Sunjung Kim, Hiren Patel, Steven J. Foltz, Gary N. Y. Chan, Kwi Hye Kim, Aaron Kopen, Lin Yang, Michael William Lawlor, Nicholas A. P. S. Buss et al. · 2026 · Molecular Therapy — Nucleic Acids
  100. Epigenome editing strategies: technological progress and in vivo applications
    Sumiyo Morita, Takuro Horii, Izuho Hatada · 2026 · BMC Methods